From pandemic to policy: leveraging COVID-19 lessons to strengthen antimicrobial stewardship
Background: The COVID-19 pandemic disrupted healthcare services, straining antimicrobial stewardship (AMS) efforts. Uncertainty about bacterial co-infections led to widespread empirical antibiotic use, heightening antimicrobial resistance (AMR) concerns. Fewer than 10% of COVID-19 patients had confirmed bacterial infections, yet over 70% received antibiotics.1 Translating research into evidence-based policies is crucial for strengthening AMS, promoting health system resilience, and ensuring preparedness for future global health emergencies.2,3 Objectives: To evaluate hospital-based AMS practices during COVID-19 and translate insights into a policy brief highlighting the pandemic’s impact, lessons learned, and recommendations for resilient, sustainable AMS and global AMR policy improvements. Methods: A comprehensive evaluation of AMS practices during COVID-19 included three studies. A literature review examined global AMS implementation over 20 years. Antibiotic prescribing patterns in 640 patients across two NHS Trust hospitals (2019–2020) were analysed. A survey of 240 healthcare professionals explored knowledge, attitudes, and perceptions of antibiotic prescribing, AMR, and stewardship.4 This was further enriched by reviewing institutional guidelines, national and global policy responses—such as WHO advisories on antibiotic use and AMR surveillance—and key governmental and published reports. Results: The findings informed the development of a policy brief5 addressing three key areas: the impact of COVID-19 on AMS, critical lessons learned during the pandemic, and strategic recommendations for building resilient and sustainable AMS practices. These outcomes highlight the importance of embedding AMS in emergency preparedness, strengthening diagnostic capacity, and ensuring evidence-based policymaking to combat AMR in future health crises. Conclusions: The COVID-19 pandemic highlighted the critical role of resilient and adaptable AMS in public health emergencies. Key lessons—such as integrating AMS into emergency planning, enhancing diagnostic capacity, and reinforcing infection prevention—must inform routine practice and preparedness strategies. Translating these insights into policy is essential to sustain AMS gains, guide AMR strategies, and ensure long-term protection of antibiotic effectiveness at national and global levels.
| Item Type | Conference or Workshop Item (Other) |
|---|---|
| Identification Number | 10.1093/jacamr/dlaf118.022 |
| Additional information | © The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). |
| Keywords | antimicrobial, antimicrobial agents, antimicrobial effectiveness, antimicrobial efficacy, antibiotics, antibiotics for pharmacists, antibiotics for doctors, empiric antibiotic use, empiric antimicrobials, empirical, empirical article, empirical data, empirical research, empirical prescribing, empirical study, bacterial co-infeciton, policy, policy analysis, policy brief, policy development, policy framework, policy implications of ams, policy in practice, policy interactions, policy support, evidence-based policy, global health, global health care, global health challenge, global health challenges, global health security, global health governance, leason learnt, sustainable, sustainable ams practices, sustainable antibiotics, sustainable development, amr surveillance, who, who aware classification, who criteria, who guidelines, translational research, survey and evaluation, united nations, united nations sdgs |
| Date Deposited | 02 Jul 2026 09:13 |
| Last Modified | 04 Jul 2026 01:09 |
